Recent NBIX Stock Price | NBIX Stock Predictions | |
$132.00 | +11.68% |
$147.42 |
Recent NBIX Analyst Ratings Breakdown, Making NBIX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 18 | 19 | 19 | 18 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 6 | 6 | 6 | 6 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.52 | 1.5 | 1.5 | 1.52 |
For the NBIX stock predictions from the analysts covering Neurocrine Biosciences, Inc., we have collected all of the individual NBIX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 24 different analysts covering NBIX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since NBIX stock predictions may vary widely, another useful metric to consider is the median NBIX stock prediction, which represents the price at which half of the analysts
made NBIX stock predictions that were higher and half made NBIX stock predictions that were lower. This makes for a different take on the NBIX stock predictions out there, as compared to average or mean.
And that median across all the individual NBIX stock predictions was: $150.0 as of 2024-04-22.
The very highest of the NBIX stock predictions for one year price target was $200.0, while the very lowest of the NBIX stock predictions in the analyst group was
$100.0 (with a standard deviation of $22.852). Get the latest Zacks research report on NBIX — FREE
Find out: NBIX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ADI Stock Predictions
CMBM Stock Predictions
KRYS Stock Predictions
TNDM Stock Predictions
GBX Stock Predictions
SBBP Stock Predictions
LEA Stock Predictions
USAC Stock Predictions
BATRA Stock Predictions
|
|
Buy (3.48 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |